AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 277 filers reported holding AMICUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,558,464 | -7.1% | 210,400 | -4.0% | 0.01% | 0.0% |
| Q2 2023 | $2,752,582 | +18.2% | 219,137 | +4.3% | 0.01% | +20.0% |
| Q1 2023 | $2,329,444 | +2.5% | 210,049 | +12.9% | 0.01% | -16.7% |
| Q4 2022 | $2,272,427 | +13.7% | 186,112 | -2.8% | 0.01% | +20.0% |
| Q3 2022 | $1,998,000 | +6.1% | 191,388 | +9.1% | 0.01% | 0.0% |
| Q2 2022 | $1,883,000 | +101.4% | 175,348 | +85.3% | 0.01% | +66.7% |
| Q1 2021 | $935,000 | -26.3% | 94,611 | +72.1% | 0.00% | -40.0% |
| Q4 2020 | $1,269,000 | +18.4% | 54,968 | -27.5% | 0.01% | 0.0% |
| Q3 2020 | $1,072,000 | +3.0% | 75,868 | -29.0% | 0.01% | -16.7% |
| Q4 2019 | $1,041,000 | +32.6% | 106,898 | +9.2% | 0.01% | +20.0% |
| Q3 2019 | $785,000 | – | 97,891 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |